(1)
Dayan, S.; Ogilvie, P.; Rivkin, A. Z.; Yoelin, S. G.; Garcia, J. K.; Ferrusi, I. L. OnabotulinumtoxinA for Treatment of Moderate-to-Severe Horizontal Lines and Glabellar Lines from the Subject’s Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study. J of Skin 2017, 1, s82.